A series of novel diaryl ureas were identified as potent antitumor agents.
Compound 13i potently suppressed proliferation of cancer cells.
Compound 13i effectively inhibited c-Kit, RET, and FLT3 kinases.
Compounds 13i significantly induced apoptosis of HT-29 cells.